Zepbound Will Compete With Other Injectables for Obesity

January 2024

You may see Rx Zepbound, a new injectable for obesity, pop up on home med lists.

But it’s not a new drug. It’s tirzepatide...the same med in injectable Mounjaro for type 2 diabetes.

Think of Zepbound as an alternative to Wegovy (semaglutide) or Saxenda (liraglutide)...the other injectables approved for obesity.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Medication Errors Reduce the Risk of Tragedies Due to Ampule Mix-Ups
Practice Use Simulations to Optimize Learning
Obesity & Weight Loss Familiarize Yourself With Oral Weight Loss Meds
Obesity & Weight Loss Zepbound Will Compete With Other Injectables for Obesity
Med Safety Ensure Oral Liquid Meds Have Directions in “mL”
Gastroenterology Voquezna Will Be a New Rx Acid Suppressant
Substance Use Disorder Prevent Mishaps With Meds for Alcohol Use Disorder
NatMed Spotlight Give Guidance About Coenzyme Q10